Next Article in Journal
A Novel C@Fe@Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma
Next Article in Special Issue
Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children
Previous Article in Journal
Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization
Previous Article in Special Issue
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(9), 1844; https://doi.org/10.3390/pharmaceutics14091844
Action Date Notes Link
article xml file uploaded 1 September 2022 12:21 CEST Original file -
article xml uploaded. 1 September 2022 12:21 CEST Update https://www.mdpi.com/1999-4923/14/9/1844/xml
article pdf uploaded. 1 September 2022 12:21 CEST Version of Record https://www.mdpi.com/1999-4923/14/9/1844/pdf
article supplementary file uploaded. 1 September 2022 12:21 CEST - https://www.mdpi.com/1999-4923/14/9/1844#supplementary
article html file updated 1 September 2022 12:22 CEST Original file https://www.mdpi.com/1999-4923/14/9/1844/html
Back to TopTop